3.23
0.12 (3.86%)
0.12 (3.86%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.12 | 3.86% | 3.23 | 07:08:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.11 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.15 | 3.23 | 0.08 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 18 | 2,623 | 4,772,349 | 1.01 - 9.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:05:08 | 45 | $ 3.23 | USD |
Arbutus Biopharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 274.26M | 84.91M | 67.23M | $ 6.01M | $ - | -2.89 | -3.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Arbutus Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABUS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.40 | 3.4701 | 3.02 | 3.25 | 1,103,614 | -0.17 | -5.0% |
| 1 Month | 3.91 | 4.07 | 3.02 | 3.45 | 1,346,528 | -0.68 | -17.39% |
| 3 Months | 3.95 | 5.14 | 2.91 | 3.95 | 2,395,954 | -0.72 | -18.23% |
| 6 Months | 3.16 | 5.87 | 2.72 | 4.02 | 2,812,263 | 0.07 | 2.22% |
| 1 Year | 1.09 | 9.00 | 1.01 | 4.14 | 3,898,113 | 2.14 | 196.33% |
| 3 Years | 5.05 | 12.60 | 0.81 | 4.09 | 1,611,164 | -1.82 | -36.04% |
| 5 Years | 5.19 | 12.60 | 0.81 | 4.11 | 1,052,733 | -1.96 | -37.76% |
Arbutus Biopharma Description
| Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology. |
